4/A

FORM 4/A SUBMISSION

Company: SANGAMO THERAPEUTICS, INC
Filed: June 3, 2020
Period of Report: May 18, 2020
Accession Number: 0001209191-20-034022

View Document ↗ View on SEC.gov ↗